申请人:Ciba-Geigy Corporation
公开号:US04278665A1
公开(公告)日:1981-07-14
The new antibiotic "Papulacandin" is obtained by the cultivation of the microorganism Papularia sphaerosperma (Pers.) Hohnel, especially of the strain NRRL 8086, under aerobic conditions in an aqueous nutrient medium. There can also be used mutants of said microorganisms. Papulacandin consists of various components A, B, C, D and E, the more important of which are A and B, whose structures have been elucidated to a great extent: they contain only carbon, hydrogen and oxygen. Papulacandin and its components have a strong anti-fungal action, for instance against Candida albicans, and can be used for combating infections caused by pathogenic fungi.
新的抗生素“Papulacandin”是通过在水溶养基中,以氧气为条件,培养微生物Papularia sphaerosperma(Pers。)Hohnel,特别是菌株NRRL 8086获得的。也可以使用该微生物的突变体。Papulacandin由各种组分A,B,C,D和E组成,其中较为重要的是A和B,它们的结构已经被详细阐明:它们仅含有碳,氢和氧。Papulacandin及其组分具有强烈的抗真菌作用,例如对Candida albicans,可以用于对抗由致病真菌引起的感染。